Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 18 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 2,816 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | AGIO | Agios Pharmaceuticals,… | MEXER | 2,816 | — | — | +22.7% | Open the original filing on SEC.gov |
| Feb 12 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 17,126 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 2,302 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | AGIO | Agios Pharmaceuticals,… | MEXER | 2,302 | — | — | +22.8% | Open the original filing on SEC.gov |
| Jun 20, 2025 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 2,120 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | AGIO | Agios Pharmaceuticals,… | MEXER | 2,120 | — | — | +26.5% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AGIO | Agios Pharmaceuticals,… | AGRANT◆ | 15,768 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | AGIO | Agios Pharmaceuticals,… | AGRANT◆ | 2,816 | — | — | — | Open the original filing on SEC.gov |